TUDCA-ALS SIGNED
Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0TUDCA-ALS project word cloud
Explore the words cloud of the TUDCA-ALS project. It provides you a very rough idea of what is the project "TUDCA-ALS" about.
Project "TUDCA-ALS" data sheet
The following table provides information about the project.
| Coordinator |
HUMANITAS MIRASOLE SPA
Organization address contact info |
| Coordinator Country | Italy [IT] |
| Project website | http://www.tudca.eu/ |
| Total cost | 5˙596˙928 € |
| EC max contribution | 5˙596˙928 € (100%) |
| Programme |
1. H2020-EU.3.1.3. (Treating and managing disease) |
| Code Call | H2020-SC1-2017-Two-Stage-RTD |
| Funding Scheme | RIA |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-01-01 to 2021-12-31 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | HUMANITAS MIRASOLE SPA | IT (ROZZANO (MI)) | coordinator | 1˙526˙994.00 |
| 2 | THE UNIVERSITY OF SHEFFIELD | UK (SHEFFIELD) | participant | 731˙906.00 |
| 3 | UNIVERSITAIR MEDISCH CENTRUM UTRECHT | NL (UTRECHT) | participant | 689˙197.00 |
| 4 | UNIVERSITAET ULM | DE (ULM) | participant | 647˙125.00 |
| 5 | BRUSCHETTINI SRL | IT (GENOVA) | participant | 516˙868.00 |
| 6 | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS | FR (TOURS CEDEX 9) | participant | 490˙906.00 |
| 7 | KATHOLIEKE UNIVERSITEIT LEUVEN | BE (LEUVEN) | participant | 352˙281.00 |
| 8 | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN | IE (DUBLIN) | participant | 351˙086.00 |
| 9 | ISTITUTO SUPERIORE DI SANITA | IT (ROMA) | participant | 239˙375.00 |
| 10 | MOTOR NEURONE DISEASE ASSOCIATION | UK (NORTHAMPTON) | participant | 51˙187.00 |
Map
Project objective
TUDCA-ALS will focus on amyotrophic lateral sclerosis (ALS) a rare neurodegenerative disorder, that affects motor neurons in the brain, brainstem and spinal cord, resulting in progressive weakness and atrophy of voluntary skeletal muscles. ALS has an estimated prevalence of 5.40 cases per 100.000 population corresponding at about 40.000 patients at European level. Treatments are modestly effective at best, and the majority of patients die within 3-5 years of diagnosis, often from respiratory failure. TUDCA-ALS is based on the results of a successful proof-of-concept trial and has the ambition to develop a novel therapy in patients with ALS, based on administration of tauroursodeoxycholic acid (TUDCA) in addition to riluzole. TUDCA-ALS aims to perform a state-of-art randomized control trial on safety and efficacy of TUDCA in patients with sporadic ALS, without cognitive involvement and to exploit the project results into a novel therapeutic treatment for ALS. The trial primary endpoint is deterioration of function measured with the ALS Functional Rating Scale Revised. The secondary endpoints are: (1) Survival time to invasive ventilation (tracheostomy) or death; (2) changes in quality of life parameters measured by the ALSAQ-40 questionnaire; (3) functional changes measured by Forced Vital Capacity, and the EQ-5D scale. Muscle force will be assessed by the MRC scale and a correlated analysis of function and survival will be performed. Two biomarkers will be measured: neurofilament levels in the CSF and serum and MMP-9 expression in serum. The latter is a possible biomarker of TUDCA efficacy. TUDCA-ALS is grounded on promising phase IIb clinical data and is expected to impact positively on the international research efforts on ALS. TUDCA-ALS aims to obtain concrete benefits for patients with ALS. If the trial will prove successful, the consortium will support the development of this treatment at European level by combining expert knowledge and patient cooperation.
Deliverables
| Dissemination and exploitation plan | Documents, reports | 2020-02-13 12:58:06 |
| Project website | Websites, patent fillings, videos etc. | 2020-02-13 12:58:06 |
Take a look to the deliverables list in detail: detailed list of TUDCA-ALS deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TUDCA-ALS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "TUDCA-ALS" are provided by the European Opendata Portal: CORDIS opendata.